Authorized purpose: Concurrent-read CADe to aid professionally trained and licensed dentists in detecting and segmenting caries on bitewing and periapical radiographs; the output is additional information and does not replace dentist review or clinical judgment.
Clinical role
Concurrent-read dental CADe for caries detection and segmentation during dentist review; the presentation layer provides a non-diagnostic viewer in which annotations can be filtered, displayed, hidden, created, or edited.
Images and patients
X-ray/Radiography · Permanent dentition and tooth surfaces in dental/maxillofacial anatomy
Key limitation
Keep in mind: Safety and effectiveness were not established on primary or mixed dentition, and use is limited to licensed dentists. The device is not a sole decision-making tool and may produce false-positive or false-negative outputs. Accuracy is not guaranteed for unlisted sensors or images below 500 x 500 resolution; incorrect image rotation can make tooth numbering and caries predictions inaccurate. Significant tooth overlap may suppress predictions unless a radiolucency remains distinctly visible.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Concurrent-read CADe to aid professionally trained and licensed dentists in detecting and segmenting caries on bitewing and periapical radiographs; the output is additional information and does not replace dentist review or clinical judgment.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Permanent dentition and tooth surfaces in dental/maxillofacial anatomy Input: Digital bitewing and periapical radiographs of permanent dentition in patients at least 12 years old; images smaller than 500 x 500 resolution are not intended. The packet describes testing with Carestream, Dexis, e2v, Gendex, Hamamatsu, Jazz Imaging, ScanX, Schick, and Soredex Digora sensors and image formats including JPG, PNG, EOP, TIFF, and DICOM.
Who uses it?Intended users: Professionally trained and licensed dentists
What does the software produce?Output: Caries detection and segmentation on the radiograph, resulting in an outline or fill of suspected caries with predictions assigned to a specific tooth; the packet distinguishes primary, secondary, enamel, and dentin caries outputs.
What is its most important limitation?Key limitation: Safety and effectiveness were not established on primary or mixed dentition, and use is limited to licensed dentists. The device is not a sole decision-making tool and may produce false-positive or false-negative outputs. Accuracy is not guaranteed for unlisted sensors or images below 500 x 500 resolution; incorrect image rotation can make tooth numbering and caries predictions inaccurate. Significant tooth overlap may suppress predictions unless a radiolucency remains distinctly visible.
Clinical takeaway. Clinical role: Concurrent-read CADe to aid professionally trained and licensed dentists in detecting and segmenting caries on bitewing and periapical radiographs; the output is additional information and does not replace dentist review or clinical judgment.
Evidence takeaway. Evidence from the reviewed source record: FDA standalone testing evaluated 1,293 bitewing images and 1,314 periapical images, including 27,920 bitewing surfaces and 16,254 periapical surfaces, against consensus labels from three US licensed dentists with oral-radiologist adjudication of non-consensus labels. Overall standalone sensitivity was 76.6% for bitewing images (95% CI 73.8%-79.4%) and 79.4% for periapical images (76.1%-82.8%); specificity was 99.1% for bitewing images (98.9%-99.2%) and 99.4% for periapical images (99.2%-99.5%). A 28-dentist reader study used 330 bitewing and 330 periapical images; assisted reader sensitivity was 78.5% and 79.0%, versus 64.6% and 65.6% unassisted, while assisted specificity was 98.6% and 97.6%, versus 99.0% and 98.0% unassisted.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Concurrent-read CADe to aid professionally trained and licensed dentists in detecting and segmenting caries on bitewing and periapical radiographs; the output is additional information and does not replace dentist review or clinical judgment.
Concurrent-read dental CADe for caries detection and segmentation during dentist review; the presentation layer provides a non-diagnostic viewer in which annotations can be filtered, displayed, hidden, created, or edited.
Digital bitewing and periapical radiographs of permanent dentition in patients at least 12 years old; images smaller than 500 x 500 resolution are not intended. The packet describes testing with Carestream, Dexis, e2v, Gendex, Hamamatsu, Jazz Imaging, ScanX, Schick, and Soredex Digora sensors and image formats including JPG, PNG, EOP, TIFF, and DICOM.
Caries detection and segmentation on the radiograph, resulting in an outline or fill of suspected caries with predictions assigned to a specific tooth; the packet distinguishes primary, secondary, enamel, and dentin caries outputs.
Safety and effectiveness were not established on primary or mixed dentition, and use is limited to licensed dentists. The device is not a sole decision-making tool and may produce false-positive or false-negative outputs. Accuracy is not guaranteed for unlisted sensors or images below 500 x 500 resolution; incorrect image rotation can make tooth numbering and caries predictions inaccurate. Significant tooth overlap may suppress predictions unless a radiolucency remains distinctly visible.
FDA standalone testing evaluated 1,293 bitewing images and 1,314 periapical images, including 27,920 bitewing surfaces and 16,254 periapical surfaces, against consensus labels from three US licensed dentists with oral-radiologist adjudication of non-consensus labels. Overall standalone sensitivity was 76.6% for bitewing images (95% CI 73.8%-79.4%) and 79.4% for periapical images (76.1%-82.8%); specificity was 99.1% for bitewing images (98.9%-99.2%) and 99.4% for periapical images (99.2%-99.5%). A 28-dentist reader study used 330 bitewing and 330 periapical images; assisted reader sensitivity was 78.5% and 79.0%, versus 64.6% and 65.6% unassisted, while assisted specificity was 98.6% and 97.6%, versus 99.0% and 98.0% unassisted.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA standalone testing evaluated 1,293 bitewing images and 1,314 periapical images, including 27,920 bitewing surfaces and 16,254 periapical surfaces, against consensus labels from three US licensed dentists with oral-radiologist adjudication of non-consensus labels. Overall standalone sensitivity was 76.6% for bitewing images (95% CI 73.8%-79.4%) and 79.4% for periapical images (76.1%-82.8%); specificity was 99.1% for bitewing images (98.9%-99.2%) and 99.4% for periapical images (99.2%-99.5%). A 28-dentist reader study used 330 bitewing and 330 periapical images; assisted reader sensitivity was 78.5% and 79.0%, versus 64.6% and 65.6% unassisted, while assisted specificity was 98.6% and 97.6%, versus 99.0% and 98.0% unassisted.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Overjet Caries Assist regulatory performance study summary
DesignStand-alone performance and reader study (ACR AI Central category)
PopulationAdult and Pediatric
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K222746
Samplen=2607
IndependenceIndependence not established
K222746
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K222746. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Digital bitewing and periapical radiographs of permanent dentition in patients at least 12 years old; images smaller than 500 x 500 resolution are not intended. The packet describes testing with Carestream, Dexis, e2v, Gendex, Hamamatsu, Jazz Imaging, ScanX, Schick, and Soredex Digora sensors and image formats including JPG, PNG, EOP, TIFF, and DICOM.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The network layer works with a practice PACS or EMR to transmit image and metadata to Overjet, and the web presentation layer displays annotations in a non-diagnostic viewer. The reviewed FDA packet does not establish a specific interface version, local compatibility, or current commercial deployment topology.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The exact FDA package describes a web platform (Edge, Chrome, Firefox) in which images are pulled in from the clinic or dental office and a network layer works with the practice PACS or EMR to transmit images and metadata to Overjet. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "Platform Web - Edge, Chrome, Firefox Web - Edge, Chrome, Firefox" … "OCA is a software-only device which operates in three layers: a Network Layer, a Presentation Layer, and a Decision Layer. Images are pulled in from a clinic/dental office". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Caries detection and segmentation on the radiograph, resulting in an outline or fill of suspected caries with predictions assigned to a specific tooth; the packet distinguishes primary, secondary, enamel, and dentin caries outputs.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Caries detection and segmentation on the radiograph, resulting in an outline or fill of suspected caries with predictions assigned to a specific tooth; the packet distinguishes primary, secondary, enamel, and dentin caries outputs.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes a web platform (Edge, Chrome, Firefox) in which images are pulled in from the clinic or dental office and a network layer works with the practice PACS or EMR to transmit images and metadata to Overjet. Current hosting, data flow, and commercial configuration require vendor confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "Platform Web - Edge, Chrome, Firefox Web - Edge, Chrome, Firefox" … "OCA is a software-only device which operates in three layers: a Network Layer, a Presentation Layer, and a Decision Layer. Images are pulled in from a clinic/dental office". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
The network layer works with a practice PACS or EMR to transmit image and metadata to Overjet, and the web presentation layer displays annotations in a non-diagnostic viewer. The reviewed FDA packet does not establish a specific interface version, local compatibility, or current commercial deployment topology.
Overjet's trust center states a completed independent HITRUST audit and certification, HIPAA business associate compliance, GDPR and CCPA alignment, third-party penetration tests, need-to-know data access and employee security training. Vendor-wide.
Vendor-wide
Checked 2026-10-25
Vendor statement, not an attestation; exact-release scope is not established.
ACR AI Central provides an exact-submission model card for Overjet Caries Assist; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
25Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K222746 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring complete dentist review and judgment.
Authorized purpose: Acts as a CADe second reader to detect and segment caries on periapical radiographs of permanent teeth in patients aged 12 years and older; clinicians review the contours and percentage analysis in context.
Authorized purpose: Aids dentists reviewing bitewing and periapical radiographs of permanent teeth by detecting/segmenting caries and periapical radiolucencies, identifying restorations and dental anatomy, and measuring mesial/distal bone levels; it does not replace dentist review.
Authorized purpose: Aid dentists in detecting and segmenting caries on bitewing and periapical radiographs for patients aged 4-11 with primary or permanent teeth; the output is additional information and does not replace a complete dental review or clinical judgment.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.